These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4376476)

  • 1. The metabolic transformation of phenylbutazone in the alloxan diabetic rat.
    Dajani RM; Saheb SE
    Comp Gen Pharmacol; 1974 Mar; 5(1):11-21. PubMed ID: 4376476
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo studies of the metabolism of phenylbutazone in the alloxan rat and rabbit.
    Dajani RM; Saheb SE
    J Pharm Pharmacol; 1971 Dec; 23():220S-221S. PubMed ID: 4401469
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of phenylbutazone on liver microsomal demethylase.
    Cho AK; Hodshon BJ; Brodie BB
    Biochem Pharmacol; 1970 May; 19(5):1817-23. PubMed ID: 5513961
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral absorption of drugs by the alloxan-diabetic rat.
    Dajani RM; Acra A
    Gen Pharmacol; 1981; 12(5):339-44. PubMed ID: 7026351
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in the activity of NADH-oxidase in rat tissues during experimental diabetes.
    Askar MA; Baquer NZ
    Biochem Mol Biol Int; 1994 Nov; 34(5):909-14. PubMed ID: 7727000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement by alloxan-induced diabetes of the rate of metabolic activation of three pyrolysate carcinogens via increase in the P-448-H content in rat liver.
    Yamazoe Y; Abu-Zeid M; Yamauchi K; Murayama N; Shimada M; Kato R
    Biochem Pharmacol; 1988 Jul; 37(13):2503-6. PubMed ID: 3291880
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of cytosol effects on the rates of microsomal drug metabolism in alloxan and streptozotocin diabetic rats.
    Past MR; Cook DE
    Biochem Pharmacol; 1980 Sep; 29(18):2499-503. PubMed ID: 6448602
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of alloxan and streptozotocin induced diabetes in rats: differential effects on microsomal drug metabolism.
    Vega P; Gaule C; Mancilla J; Del Villar E
    Gen Pharmacol; 1993 Mar; 24(2):489-95. PubMed ID: 8482528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
    Varma DR
    Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal and peroxisomal fatty acid oxidation in streptozotocin diabetic rat liver.
    Orellana M; Valdés E; Del Villar E
    Gen Pharmacol; 1997 Mar; 28(3):361-4. PubMed ID: 9068973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen levels in brain & liver of normal alloxan-diabetic & insulinized rats.
    Prasannan KG
    Indian J Exp Biol; 1973 Jul; 11(4):331-2. PubMed ID: 4783385
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of streptozotocin-induced diabetes in the rat on the metabolism of fluorinated volatile anesthetics.
    Pantuck EJ; Pantuck CB; Conney AH
    Anesthesiology; 1987 Jan; 66(1):24-8. PubMed ID: 3541691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alloxan-diabetes and subsequent treatment with insulin on lipid/phospholipid composition of rat brain microsomes and mitochondria.
    Patel SP; Katyare SS
    Neurosci Lett; 2006 May; 399(1-2):129-34. PubMed ID: 16483714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered metabolism of androstenedione by hepatic microsomes from streptozotocin-diabetic male rats.
    Reinke LA; Rosenberg H; Stohs SJ
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):445-52. PubMed ID: 653101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloxan diabetes and in vitro protein biosynthesis in rat liver microsomes and mitochondria.
    KORNER A
    J Endocrinol; 1960 May; 20():256-65. PubMed ID: 14411069
    [No Abstract]   [Full Text] [Related]  

  • 16. Disposition and oxidative metabolism of phenylbutazone in man.
    Aarbakke J; Bakke OM; Milde EJ; Davies DS
    Eur J Clin Pharmacol; 1977; 11(5):359-66. PubMed ID: 880975
    [No Abstract]   [Full Text] [Related]  

  • 17. Nature of the increase in liver microsomal glucose-6-phosphatase activity during the early stages of alloxan-induced diabetes.
    Jakobsson SV; Dallner G
    Biochim Biophys Acta; 1968 Oct; 165(3):380-92. PubMed ID: 4311516
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of an extract from the roots of bryony (Bryonia alba) on lipid peroxidation in the liver of rats with alloxan diabetes].
    Karagezian KG; Vartanian GS; Panosian AG
    Biull Eksp Biol Med; 1981 Aug; 92(8):35-7. PubMed ID: 7295964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of alloxan-diabetes potentiation of carbon tetrachloride-induced liver necrosis.
    Villarruel MC; Fernández G; de Ferreyra EC; de Fenos OM; Castro JA
    Br J Exp Pathol; 1982 Aug; 63(4):388-93. PubMed ID: 6758834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of insulin action by bradykinin in the alloxan-diabetic rat.
    Wicklmayr M; Dietze G
    FEBS Lett; 1979 Oct; 106(1):125-8. PubMed ID: 499484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.